GCL vs NIVF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

GCL

38.5
AI Score
VS
NIVF Wins

NIVF

45.9
AI Score

Investment Advisor Scores

GCL

39score
Recommendation
SELL

NIVF

46score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric GCL NIVF Winner
Revenue 238.92M 4.73M GCL
Net Income -25.00M 9.88M NIVF
Gross Margin 10.3% 20.2% NIVF
Net Margin -10.5% 209.0% NIVF
Operating Income -13.27M -10.73M NIVF
ROE -67.9% 37.1% NIVF
ROA -13.6% 30.2% NIVF
Total Assets 183.18M 32.72M GCL
Cash 36.58M 758,621 GCL
Current Ratio 1.52 3.12 NIVF
Free Cash Flow -11.65M -11.06M NIVF

Relative Price Performance (Last 90 Days)

GCL 1M: +21.8% · 3M: +72.2% NIVF 1M: -76.8% · 3M: -84.6%

Current Technical Phase

GCL

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (22.3% over 20 days), RSI 59

RSI (14): 59.3 · Price: $0.84

NIVF

Markdown
Sell / avoid

Price below a falling SMA50 (slope -34.9%), weak momentum, RSI 40

RSI (14): 39.6 · Price: $0.19

Fundamentals Snapshot

Metric GCL NIVF
Market Cap — —
Forward P/E 0.0 0.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.5% 0.0%
Gross Margin 0.1% 0.2%
Operating Margin 0.0% -1.8%
EPS -0.20 -3784.13
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, NIVF is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.